SCHEMBL8207291

SCHEMBL8207291

C#COc1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 3/20 0.43
HPGD P15428 2/20 0.38
SLC6A4 P31645 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A3 Q01959 2/20 0.37
ALDH1A1 P00352 2/20 0.36
HTT P42858 2/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CXCL8 P10145 1/20 0.36
DPP4 P27487 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8975966 0.81 ALDH1A1 (0.41) LMNASMN1; SMN2TSHRSLC6A4SLC6A2
SCHEMBL11851873 0.78 LMNA (0.42) LMNASMN1; SMN2TSHRHPGDSLC6A4
SCHEMBL54888 0.78 LMNA (0.47) LMNASMN1; SMN2TSHRHPGDSLC6A4
SCHEMBL8975977 0.76 LMNA (0.41) LMNASMN1; SMN2TSHRHPGDSLC6A4
SCHEMBL9329848 0.75 HPGD (0.47) LMNATSHRHPGDL3MBTL1SLC6A2
SCHEMBL18660553 0.75 TP53 (0.42) LMNATSHRHPGDSLC6A2SLC6A3
SCHEMBL6219566 0.73 L3MBTL1 (0.38) L3MBTL1SLC6A2SLC6A3ALDH1A1MEN1
SCHEMBL7558433 0.73 HTR7 (0.38) LMNASMN1; SMN2HPGDL3MBTL1ALDH1A1
SCHEMBL8975558 0.73 TSHR (0.43) SMN1; SMN2TSHRALDH1A1MEN1KMT2A
SCHEMBL6221752 0.73 CA1 (0.62) LMNASMN1; SMN2TSHRHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0759929-B1 OXIDATION OF STEROIDS HAVING ALLYLIC GROUPS MERCK & CO INC (US) 2000-08-23 EP claimed
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 EP claimed